key: cord-0730543-jm9gzc18 authors: Ma, Yunlong; Huang, Yukuan; Zhao, Sen; Yao, Yinghao; Zhang, Yaru; Qu, Jia; Wu, Nan; Su, Jianzhong title: Integrative Genomics Analysis Reveals a 21q22.11 Locus Contributing Risk to COVID-19 date: 2021-05-05 journal: Hum Mol Genet DOI: 10.1093/hmg/ddab125 sha: b3e578977b8bff28e0c060ac4b3f905113e4b1ad doc_id: 730543 cord_uid: jm9gzc18 The systematic identification of host genetic risk factors is essential for the understanding and treatment of COVID-19. By performing a meta-analysis of two independent genome-wide association summary datasets (N = 680 128), a novel locus at 21q22.11 was identified to be associated with COVID-19 infection (rs9976829 in IFNAR2-IL10RB, OR = 1.16, 95% CI = 1.09–1.23, P = 2.57 × 10(−6)). The rs9976829 represents a strong splicing quantitative trait locus for both IFNAR2 and IL10RB genes, especially in lung tissue (P = 1.8 × 10(−24)). Integrative genomics analysis of combining GWAS with eQTL data showed the expression variations of IFNAR2 and IL10RB have prominent effects on COVID-19 in various types of tissues, especially in lung tissue. The majority of IFNAR2-expressing cells were dendritic cells (40%) and plasmacytoid dendritic cells (38.5%), and IL10RB-expressing cells were mainly nonclassical monocytes (29.6%). IFNAR2 and IL10RB are targeted by several interferons-related drugs. Together, our results uncover 21q22.11 as a novel susceptibility locus for COVID-19, in which individuals with G alleles of rs9976829 have a higher probability of COVID-19 susceptibility than those with non-G alleles. showing suggestive associations with COVID-19 (P < 1 × 10 -3 , Supplemental Table S1 ). Meanwhile, we performed two MAGMA gene-based association analyses for COVID_I GWAS summary data from Ellinghaus et al. (11) and the COVID-19 Host Genetic Consortium (ANA5) (2), respectively. We found that these nine identified genes showed significant or suggestive associations with COVID-19 in both COVID-I and ANA5 datasets ( Table 2 ), indicating that our meta-analysis based on larger samples enhance the statistical power to uncover risk genes for COVID-19. As mentioned above, there were 41 genes showing significant or suggestive associations with COVID-19 (P < 1 × 10 -3 , Supplemental Table S1 ). We performed a pathway enrichment analysis of these 41 identified genes for COVID-19 susceptibility (Methods), and found they were significantly interferon-stimulated genes to prevent viral replication (12). Network-based enrichment analysis showed that these 41 genes are at least partially biologically connected (P = 0.013, Supplemental Figure S8 ). These results suggest cytokine-related pathways or functional terms may play important roles in the process of COVID-19 infection. To highlight the functional association of these 11 identified genes with COVID-19, we conducted two independent integrative genomics analyses by incorporating meta-GWAS summary data with eQTL data across 49 GTEx tissues. Using S-PrediXcan analysis, we found that the expression variations of these 11 genes have prominent effects on COVID-19 in various types of tissues (Supplemental Table S5 ). Consistently, Sherlock-based integrative genomics analysis showed seven genes including IFNAR2 and IL10RB whose genetically regulated expression were significantly associated with COVID-19 across multiple tissues (Supplemental Table S6 ). For example, the IFNAR2 gene was associated with COVID-19 across six tissues including lung (P = 2.44 × 10 -4 ). The IL10RB gene showed associations with COVID-19 across 24 tissues with the most significant tissue of cells-transformed fibroblasts (P = 2.80 × 10 -5 ). We further used S-MultiXcan to meta-analyze the tissue-specific associations from S-PrediXcan across 49 GTEx tissues, and found these 11 genes whose expression were significantly associated with COVID-19, which support our results from the MAGMA analysis (Figure 3c and Supplemental Table S7 ). Additionally, our in silico permutation analysis also showed that genes identified from MAGMA analysis had a significantly higher overlap with S-MultiXcan-identified genes than random events (permuted P < 1 × 10 -5 ; Figure 3d ). To examine the links between tissue-specific gene expression profiles and COVID-19 gene associations, we conducted a MAGMA gene-property analysis in 53 specific tissue types and 30 general tissue types. We found that the association signals were enriched in lung, thyroid, and esophagus tissue in 30 general tissue types (Supplemental Figure S4a ). In the analysis of 53 specific tissues, COVID-19 gene associations were also enriched in lung, cultured fibroblasts, and thyroid (Supplemental Figure S4b ). These results suggest that these identified genes for COVID-19 may have important functions in lung tissue. Using 50 cell populations across four compartments (epithelial, endothelial, stromal, and immune) of lung tissue, we identified the primarily expressed cells of these 11 risk genes associated with COVID-19 ( Figure 4 , Supplemental Table S4 , and Supplemental Figure S5 ). The HNRNPK gene was widely expressed in various cell types across all four compartments (Supplemental Figure S6 ). However, the majority of IFNAR2-expressing cells were dendritic cells (40%) and plasmacytoid dendritic cells (38.5%) ( Figure 4 ). The IFNAR2 was also expressed within lipofibroblast (20%), ciliated (19.1%) and nonclassical monocyte (18.5%), albeit at diminished abundance compared with dendritic cells; IL10RB was primarily expressed within nonclassical monocyte (29.6%). Plasmacytoid dendritic cells produce large amounts of type I interferons-proteins that are important for immunity to viruses (13, 14). To further validate the cell-specific expression of IFNAR2 and IL10RB, we re-performed the scRNA-seq analysis in two reported large-scale datasets based on peripheral immune cells and lung tissue (15, 16). Based on the scRNA-seq data on lung tissue, we found these two genes were highly expressed in monocyte-like cells (30.21% for IFNAR2 and 32.52% for IL10RB, Supplemental Table S8 ). Consistently, these two genes remained to be highly expressed in monocyte-like cells (36.27% for IFNAR2 and 35.02% for IL10RB) in the peripheral scRNA-seq dataset. These two genes also showed their expressions in dendritic cells in both scRNA-seq datasets (Supplemental Tables S8-S9 and Supplemental Figure S10 ). Our findings indicated that IFNAR2 and IL10RB could play regulatory roles in the pulmonary immune response. By performing a drug-gene interaction analysis and literature mining, we found that seven of 11 COVID-19-associated genes (63.6%) were enriched in five potential "druggable" gene categories (Supplemental Table S10 and Supplemental Figure S7 ). The gene of CCR9 is targeted by two FDA-approved drugs including hydroxyurea and hydralazine (Supplemental Table S11 ). There are nine FDA-approved drugs showing agonist-receptor interactions with IFNAR2 (Supplemental Table S11 ), including interferon alfa-2a, interferon alfacon-1, and interferon beta-1a, which could be useful alone or in combination with other antiviral drugs for treating SARS-CoV infection (17). Loutfy et al. (18) reported that interferon alfacon-1 plus corticosteroids showed association with improved oxygen saturation and more rapid resolution of radiographic lung opacities than systemic corticosteroid alone in severe acute respiratory syndrome (SARS). Treatment with interferon has shown preliminary benefits for patients with COVID-19 (19) and is being evaluated by numerous ongoing clinical trials. The IFN-beta treatment could effectively block SARS-CoV-2 replication (20). The IL10RB gene is targeted by peginterferon lambda-1a (Supplemental Table S11 ), which has been designed to treat mild COVID-19 in a clinical trial (identifier: NCT04331899). These results suggest that interferons associated with IFNAR2 and IL10RB exert potential effects on the treatment of COVID-19. On chromosome 21q22.11, the peak association signal covered two genes of IFNAR2 and IL10RB, which have biological functions that probably related to COVID-19. Subsequently, we used two widely-used tools (i.e., S-PrediXcan and Sherlock) to integrate GWAS summary data with eQTL data across 49 GTEx tissues independently for determining whether these two identified risk genes (IFNAR2 and IL10RB) with genetic variants affect COVID-19 through dysregulation of gene expression traits. In light of multi-tissue data can be leveraged to identify genes and pathways influenced by human disease-associated variation, it is plausible to combine information available across multiple tissues in GTEx for mechanistically explain gene regulation and the genetic basis of disease (22) . Thus, we further leveraged the S-MultiXcan tool to examine the mediating role of gene expression variation on COVID-19 by combining information across all 49 tissues collectively with GWAS summary statistics. Based on these analyses, we found that genetically predicted gene expression of both IFNAR2 and IL10RB are significantly associated with COVID-19 infection among multiple tissues, such as lung, artery coronary, liver, blood and heart, of which tissue-specific comorbidities including hypertension, asthma, diabetes, and liver diseases have been reported to be associated with COVID-19 infection (23) (24) (25) . These results provided supportive evidence of both IFNAR2 and IL10RB genes could be good candidates for uncovering the etiology of COVID-19. IFNAR2 encodes a type I membrane protein, which forms one of the two chains of a receptor for interferons alpha and beta. The deficiency of IFNAR2 supports an essential role for interferons alpha and beta in human antiviral immunity (26) . Notably, dysregulation of type I interferon response has been observed in COVID-19 patients (27) . Impaired type I interferon activity in the blood could be a hallmark of severe COVID-19 (28) . Furthermore, IFNAR2 is required for anti-influenza immunity and related to the risk of post-influenza bacterial superinfections (29) . As for IL10RB, its encoded protein belongs to the cytokine receptor family and is an accessory chain essential for the active interleukin 10 receptor complex. Variants in IFNAR2 and IL10RB gene were associated with the susceptibility to hepatitis B virus (HBV) infection (30) . Most recently, the interferon pathway is promoters has important roles in HEV replication (41) . Two cellular RNA binding proteins of hnRNPK and NS1-BP have important roles in regulating influenza A virus RNA splicing (42) . As for the RMI1 gene, its protein is an essential component of the RMI complex, which has a crucial role in 13 DNA repair and maintaining genome stability (43 and TMPRSS2 for COVID-19 susceptibility by testing genetic variants in these two genes from approximately 81,000 human genomes, and indicated that genetic variants in ACE2 and TMPRSS2 were likely associated with genetic susceptibility of COVID-19, which were replicated by other studies (52) . Together, these reported COVID-19-related genes could be treated as good candidate genes for future studies. The power of our study is limited by the difference in study design between the two datasets we For This GWAS summary statistics of the publicly available COVID-19 HGI GWAS meta-analyses By using the meta-analysis tool of METAL (54), a fixed-effects meta-analysis was performed to Figure S9A ). Furthermore, all the top-ranked SNPs identified from our meta-GWAS analysis obtained non-significant heterogeneous results (Supplemental Figure S9B) . Thus, the fixed-effects model applied in the current analysis is reasonable. The qqman package in R platform was used to generate Manhattan plot and quantile-quantile (QQ) plot. The web-access tool of LocusZoom (55) was used to visualize regional association plots (http://locuszoom.sph.umich.edu/). To further explore the regulatory function of identified risk SNPs, we performed cis-sQTL and cis-eQTL analysis based on the Genotype-Tissue Expression (GTEx) project data (version 8, dbGaP Accession phs000424.v8.p2). RNA-seq expression outliers were excluded by using a multidimensional extension of the statistics (56) . Samples with < 10 million mapped reads were excluded. For each gene in given tissue, expression value was normalized across samples using TMM as implemented in edgeR (57) . Using LeafCutter (58) to compute the intron excision phenotypes for quantifying splicing values. The genotype data used for analysis were based on genome-wide sequencing from 838 donors, which all had RNA-seq data available in GTEx version 8. The tool of FastQTL (59) was used to perform cis-sQTL and cis-eQTL analyses. Data visualization were performed by using the web-access tool of GTEx portal (www.gtexportal.org) (60). We conducted a gene-based association analysis of our meta-GWAS summary data for COVID-19 by using the Multi-marker Analysis of GenoMic Annotation (MAGMA) (61), which utilizes a multiple regression method to identify multi-marker aggregated effects that account for SNP P values and linkage disequilibrium (LD) between SNPs. The analyzed SNP set of each gene was based on whether the SNP located in the gene body region or within extended +/-20 kb downstream or upstream of the gene. The LDs among SNPs were calculated based on the 1,000 Genomes Phases 3 European Panel (62) . The Benjamini-Hochberg false discovery rate (FDR) method was used to correct the association results for multiple testing. The P value threshold of 1.86 ×10 -5 was applied. To annotate the molecular functions and biological pathways of these COVID-19-associated Table S2 ), we performed a functional enrichment analysis by using the and gene ontology (GO) terms. Using the overrepresentation analysis, the WebGestalt could identify functional association between COVID-19-associated genes and KEGG pathways. Furthermore, GO enrichment analysis was performed by using 3 categories of GO terms: biological process, cellular component, and molecular function. The redundancies of GO-terms were removed. The hypergenometric test was applied to assess the statistical significance. P values were corrected for multiple testing using the FDR, and a P value threshold of 2.9 ×10 -4 was applied. We performed a MAGMA gene-property analysis (61) , which is implemented in FUMA (64). The gene expression data from 83 tissues GTEx RNA-seq data (version 8) were used to parse the gene expression profiles. Expression values (TPM) were log2 transformed and average expression values were adopted per tissue. The gene-property analysis was conducted for 53 specific tissue types and 30 general tissue types, respectively. Bonferroni correction for multiple testing was used for the examined tissue types. We performed single-cell data analysis from normal lung tissue sequenced by using Smart-Seq2. This data set is a part of the Human Lung Atlas (65) , consisting of 50 cell populations across 4 compartments (epithelial, endothelial, stromal, and immune) of lung tissue. All 9,404 cells with distinct cellular identities were download from the Human Lung Atlas. Cells from 3 donors with FACS-sorted strategy were available at the Synapse (accession numbers: syn22168639, syn22168625, and syn22168622). We applied S-PrediXcan (66) To further validate these identified host genes for COVID-19, we also applied an independent approach of Sherlock-based integrative genomics analysis based on a Bayesian inference algorithm COVID-19, a negative score would be assigned; 3) no score was assigned if an SNP was not eSNP but showed a significant association with COVID-19. The Sherlock applied the simulation analysis to compute the p value of the Bayes factor for each gene, as reference of a method of Bayes/non-Bayes compromise (69) . We used the Bonferroni correction method to correct the significance for multiple testing. Due to we tested the Sherlock analysis in 49 GTEx tissues, there existed different thresholds across tissues. For example, the P value threshold was 6.64 ×10 -6 (0.05/7,529) for lung tissue. To determine whether there exist a higher overlapped rate of genes identified from MAGMA analysis (Gene set #1: N = 1,005, P < 0.05) with genes from S-MultiXcan analysis (Gene set #2: N = 1,141, P < 0.05) than that from random selections, we conducted a computer-based permutation analysis of 100,000 times of random selections (70, 71) . First, we counted the overlapped genes between Gen sets #1 and #2 (N observation ). Secondly, we used all tested genes from S-MultiXcan analysis as background genes (N background = 22,326 genes). Then, through randomly selecting the same number of genes as Gene set #2 from background genes to compare with Gene set #1 for 100,000 times, we counted the number of overlapped genes in each time (N random ). In the third step, we summed the counts of N observation ≤ N random and divided by 100,000 to calculate empirically permuted P value. P < 0.05 is considered to be significant. We submitted these 11 COVID-19-associated genes into the widely-used Drug Gene Interaction a) Manhattan plot of the meta-analysis GWAS summary statistics highlighting three susceptibility loci for COVID-19. The Manhattan plot is shown of the meta-GWAS summary statistics of meta-analyzing the COVID_I GWAS data (controlled for potential population stratification) with ANA5 GWAS data. The red horizontal line marks the genome-wide significance threshold of a P value less than 5 × 10 -8 . b) Quantile-quantile (QQ) plot of the meta-analysis GWAS summary statistics. All 8,424,883 high-quality SNPs with a MAF ≥ 1% and imputation R 2 ≥ 0.6 were used for plotting. In QQ plot the 2.5 th and 97.5 th centiles of the distribution under random sampling and the null hypothesis form the 95% concentration band. The genomic inflation factor lambda (λ) is 1.0075. c) Regional association plot for 21q22.11 locus of meta-GWAS summary statistics. Regional association plot is shown for 21q22.11 locus of the meta-GWAS summary statistics of meta-analyzing the COVID_I GWAS data (controlled for potential population stratification) with ANA5 GWAS data. The purple diamond marks the most strongly associated SNP of rs9976829 with COVID-19. The color illustrates LD information with rs9976829, as shown in the color legend. 1.86×10 -5 < P ≤ 1×10 -3 , green marks genes with 1×10 -3 < P ≤ 0.05, and gray represents genes with P > 0.05). Administration. Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia Genetic mechanisms of critical illness in Covid-19 Genetic effects on gene expression across human tissues COVID-19 in a designated infectious diseases hospital outside Hubei Province COVID-19 and comorbidities: Deleterious impact on infected patients 2020) COVID-19 and Diabetes: A Collision and Collusion of Two Diseases Human IFNAR2 deficiency: Lessons for antiviral immunity Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation An IL-7 fusion protein that shows increased thymopoietic ability Identification of HNRNPK as regulator of hepatitis C virus particle production Protein Interactions Network of Hepatitis E Virus RNA and Polymerase With Host Proteins Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing RMI1 contributes to DNA repair and to the tolerance to camptothecin A Neanderthal OAS1 isoform Protects Against COVID-19 Susceptibility and Severity: Results from Mendelian Randomization and Case-Control Studies. medRxiv, in press Integrative analyses identify susceptibility genes underlying COVID-19 hospitalization. medRxiv, in press AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci. medRxiv, in press Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity The major genetic risk factor for severe COVID-19 is inherited from Neanderthals New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor FlashPCA2: principal component analysis of Biobank-scale genotype datasets METAL: fast and efficient meta-analysis of genomewide association scans LocusZoom: regional visualization of genome-wide association scan results Heritability and genomics of gene expression in peripheral blood A scaling normalization method for differential expression analysis of RNA-seq data Annotation-free quantification of RNA splicing using LeafCutter Fast and efficient QTL mapper for thousands of molecular phenotypes The Genotype-Tissue Expression (GTEx) project MAGMA: generalized gene-set analysis of GWAS data A global reference for human genetic variation WebGestalt: an integrated system for exploring gene sets in various biological contexts Functional mapping and annotation of genetic associations with FUMA A molecular cell atlas of the human lung from single cell RNA sequencing. bioRxiv, in press Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics Integrating predicted transcriptome from multiple tissues improves association detection Sherlock: detecting gene-disease associations by matching patterns of expression QTL and GWAS Imputation-based analysis of association studies: candidate regions and quantitative traits Integrative genomics analysis of various omics data and networks identify risk genes and variants vulnerable to childhood-onset asthma Integrated genomics analysis highlights important SNPs and genes implicated in moderate-to-severe asthma based on GWAS and eQTL datasets We thanks to the helpful suggestions of Dr. Guijun Zhang. We appreciate all the authors from the COVID-19 Host Genetic Consortium, as well as Ellinghaus and his colleagues who have deposited and shared GWAS summary data on public databases. The authors declare no conflict of interest. GA G with ANA5 GWAS summary data.